In a statement Thursday, Genentech CMO Levi Garraway called the disease-free survival data unprecedented. April 18 Product: Takedas Entyvio Indication: Crohns disease The FDA on Thursday approved a subcutaneous (SC) form of Takedas Entyvio for maintenance therapy in adults with moderately to severely active Crohns disease (CD) after induction therapy with intravenous Entyvio
Generation of biofilm supernatants P
The o -vanillin plus fludioxonil pairing did not allow these mutants to develop tolerance to fludioxonil, resulting in 100% mortality (Figure 3A)
CrossRef Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim Scientific Reports .2025;[Epub] CrossRef Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study Hyun Bin Choi, Jae Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim Journal of Korean Medical Science .2025;[Epub] CrossRef Statin use is associated with better postoperative prognosis among patients with hepatitis B virusrelated hepatocellular carcinoma Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, JinHa Yoon, Beom Kyung Kim European Journal of Clinical Investigation .2023;[Epub] CrossRef Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy Jae Seung Lee, ChanYoung Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim Alimentary Pharmacology & Therapeutics .2023
